glutathione and cancer cells A study from the Birsoy lab showed that the antioxidant glutathione, when operating inside mitochondria, is a key factor enabling tumors to spread from the breast to the lung. #RockefellerScience #YearInReview Glutathione Depletion and Stalwart Anticancer

17 , e2000470 (2020)

Advanced glycation end products (AGEs) Heterogenous molecules originating from the nonenzymatic reaction of glucose or other saccharides with proteins or lipids are termed advanced glycation end products (AGEs) (Perrone et al

[DOI] [PubMed] [Google Scholar] 109.Achebak H., Garatachea R., Pay M.T., Jorba O., Guevara M., Prez Garca-Pando C., Ballester J

For patients with a personal history of any cancer, even if treated, resolved and with all signs removed, this is generally an area of discussion that is longer and frequently requires an oncology clearance beforehand

Diurnal rhythm of plasma immunoreactive corticotropin-releasing factor in normal subjects

The aim of this narrative review is to provide a broad overview on the pharmacologic aspects of glutathione, with a focus on current clinical data on its use for metabolic liver disease